304449-84-1

Basic information

• Product Name: 5-carboxyfluorescein N-hydroxysuccinimide ester
• Synonyms: 5-carboxyfluorescein N-hydroxysuccinimide ester
• CAS NO: 304449-84-1
• Molecular Weight: 473.395
• Mol File: 304449-84-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 5-carboxyfluorescein N-hydroxysuccinimide ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-carboxyfluorescein N-hydroxysuccinimide ester(304449-84-1)
• EPA Substance Registry System: 5-carboxyfluorescein N-hydroxysuccinimide ester(304449-84-1)

Safety Data

• Hazardous Substances Data: 304449-84-1(Hazardous Substances Data)

Upstream product

• 6066-82-6 1-hydroxy-pyrrolidine-2,5-dione 
• 500533-95-9 5-carboxyfluorescein 
• 76823-03-5 5-carboxyfluoroscein 
• 108-46-3 recorcinol 
• 552-30-7 trimellitic Anhydride 

Downstream Products

• 383372-58-5 N-{3-[4-(2-tert-butoxycarbonylamino-2-carboxy-ethyl)-phenyl]-prop-2-ynyl}-6-(6-hydroxy-3-oxo-3H-xanthen-9-yl)-isophthalamic acid 

Relevant articles and documents

In vivo targeting of tumor-associated carbonic anhydrases using acetazolamide derivatives

We describe the synthesis and characterization of two acetazolamide derivatives containing either a charged fluorophore or an albumin-binding moiety, which restrict binding to carbonic anhydrase IX and XII present on tumor cells. In vivo studies showed th

Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides

Tripodal peptide analogues were designed on the basis of the phosphotyrosine binding pocket of the Src SH2 domain and assayed for their ability to bind to fluorescein-labeled phosphopeptides. Fluorescence polarization assays showed that a number of amphip

COMPOUND

In one aspect, there is provided a fluorescent iron-binding compound bound to a solid phase. Also provided is a method for detecting non-transferrin bound iron in a sample, comprising contacting the sample with a fluorescent iron-binding compound bound to a solid phase and detecting a fluorescent signal derived from the fluorescent iron-binding compound bound to the solid phase, wherein the fluorescent signal is indicative of non-transferrin bound iron levels in the sample. Further provided is use of a fluorescent iron-binding compound bound to a solid phase to detect non-transferrin bound iron in a sample.